CABE-T3.1
(Plasmid
#193267)
-
PurposeExpression of CABE-T3.1 base editor in mammalian cells, CMV promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 193267 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneCMV/pBR322
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCABE-T3.1
-
SpeciesOther
-
MutationD10A (Cas9), TadA mutations within
- Promoter CMV
Cloning Information
- Cloning method Ligation Independent Cloning
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
CABE-T3.1 was a gift from Nicole Gaudelli (Addgene plasmid # 193267 ; http://n2t.net/addgene:193267 ; RRID:Addgene_193267) -
For your References section:
Improved cytosine base editors generated from TadA variants. Lam DK, Feliciano PR, Arif A, Bohnuud T, Fernandez TP, Gehrke JM, Grayson P, Lee KD, Ortega MA, Sawyer C, Schwaegerle ND, Peraro L, Young L, Lee SJ, Ciaramella G, Gaudelli NM. Nat Biotechnol. 2023 Jan 9. doi: 10.1038/s41587-022-01611-9. 10.1038/s41587-022-01611-9 PubMed 36624149